02 MarOne phase I clinical trial from TPR 287.

The Julius Springer Prize for Applied Physics recognizes researchers outstanding and innovative outstanding and innovative contributions to the fields of applied physics. It has been awarded annually since 1998 by the Editors-in – Chief of the Springer – – Materials Science & Processing and Applied Physics B – Lasers and Optics.

Nanostructures are the future of electronics and optoelectronicsThis year’s Julius Springer Prize for Applied Physics will Phaedon Avouris and Tony Heinz are awarded for their pioneering work on the electrical and optical properties from nanoscale carbon materials, including carbon nanotubes – exciting of basic research applications. The award, accompanied by $ 5,000 will be presented at the Julius Springer Forum on Applied Physics 2008 from Harvard University in Cambridge, September 2008.. One phase I clinical trial from TPR 287, the next-generation the taxane administered to everyone 21 days with patients with advanced cancer demonstrated. .